Suppr超能文献

滤泡性淋巴瘤的危险因素

Risk Factors of Follicular Lymphoma.

作者信息

Ma Shuangge

机构信息

School of Public Health, Yale University.

出版信息

Expert Opin Med Diagn. 2012 Jul 1;6(4):323-333. doi: 10.1517/17530059.2012.686996. Epub 2012 May 8.

Abstract

INTRODUCTION

Non-Hodgkin Lymphoma (NHL) is a heterogeneous group of malignancies with over thirty different subtypes. Follicular lymphoma (FL) is the most common form of indolent NHL and the second most common form of NHL overall. It has morphologic, immunophenotypic and clinical features significantly different from other subtypes. Considerable effort has been devoted to the identification of risk factors for etiology and prognosis of FL. These risk factors may advance our understanding of the biology of FL and have an impact on clinical practice. AREAS COVERED: The epidemiology of NHL and FL is briefly reviewed. For FL etiology and prognosis separately, we review clinical, environmental and molecular (including genetic, genomic, epigenetic and others) risk factors suggested in the literature. EXPERT OPINION: A large number of potential risk factors have been suggested in recent studies. However, there is a lack of consensus, and many of the suggested risk factors have not been rigorously validated in independent studies. There is a need for large-scale, prospective studies to consolidate existing findings and discover new risk factors. Some of the identified risk factors are successful at the population level. More effective individual-level risk factors and models remain to be identified.

摘要

引言

非霍奇金淋巴瘤(NHL)是一组异质性恶性肿瘤,有三十多种不同亚型。滤泡性淋巴瘤(FL)是惰性NHL最常见的形式,也是NHL总体上第二常见的形式。它具有与其他亚型显著不同的形态学、免疫表型和临床特征。人们已投入大量精力来确定FL病因和预后的危险因素。这些危险因素可能会增进我们对FL生物学的理解,并对临床实践产生影响。

涵盖领域

简要回顾了NHL和FL的流行病学。对于FL的病因和预后,我们分别回顾了文献中提出的临床、环境和分子(包括遗传、基因组、表观遗传等)危险因素。

专家观点

近期研究提出了大量潜在危险因素。然而,目前尚未达成共识,且许多提出的危险因素尚未在独立研究中得到严格验证。需要进行大规模的前瞻性研究,以巩固现有发现并发现新的危险因素。一些已确定的危险因素在人群层面取得了成功。更有效的个体层面危险因素和模型仍有待确定。

相似文献

1
Risk Factors of Follicular Lymphoma.
Expert Opin Med Diagn. 2012 Jul 1;6(4):323-333. doi: 10.1517/17530059.2012.686996. Epub 2012 May 8.
2
Risk Factors of Non-Hodgkin Lymphoma.
Expert Opin Med Diagn. 2011 Nov 1;5(6):539-550. doi: 10.1517/17530059.2011.618185.
4
The discovery and the development of bendamustine for the treatment of non-Hodgkin lymphoma.
Expert Opin Drug Discov. 2016 Nov;11(11):1123-1130. doi: 10.1080/17460441.2016.1233174. Epub 2016 Sep 16.
5
Non-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma.
Arch Med Res. 2015 Aug;46(6):454-61. doi: 10.1016/j.arcmed.2015.07.004. Epub 2015 Jul 31.
6
An analysis of genetic targets for guiding clinical management of follicular lymphoma.
Expert Rev Hematol. 2020 Dec;13(12):1361-1372. doi: 10.1080/17474086.2020.1850252. Epub 2020 Dec 4.
7
Follicular lymphomas and their transformation: Past and current research.
Expert Rev Hematol. 2017 Jun;10(6):515-524. doi: 10.1080/17474086.2017.1326812. Epub 2017 May 16.
9
Rituximab in the treatment of non-Hodgkin's lymphoma--a critical evaluation of randomized controlled trials.
Expert Opin Biol Ther. 2013 May;13(5):803-11. doi: 10.1517/14712598.2013.786698.
10
Burden of illness of follicular lymphoma and marginal zone lymphoma.
Ann Hematol. 2019 Jan;98(1):175-183. doi: 10.1007/s00277-018-3501-8. Epub 2018 Oct 13.

引用本文的文献

1
Lymphocytic Interstitial Pneumonia Presenting as an Enlarging Pulmonary Nodule in a 65-Year-Old Woman: A Case Report.
Cureus. 2025 Jul 25;17(7):e88787. doi: 10.7759/cureus.88787. eCollection 2025 Jul.
2
Single-Agent and Associated Therapies with Monoclonal Antibodies: What About Follicular Lymphoma?
Cancers (Basel). 2025 May 8;17(10):1602. doi: 10.3390/cancers17101602.
5
Upward trend in follicular lymphoma among the Korean population: 10-year experience at a large tertiary institution.
J Pathol Transl Med. 2021 Sep;55(5):330-337. doi: 10.4132/jptm.2021.07.25. Epub 2021 Sep 2.
6
Incidence and mortality trends and geographic patterns of follicular lymphoma in Canada.
Curr Oncol. 2019 Aug;26(4):e473-e481. doi: 10.3747/co.26.4625. Epub 2019 Aug 1.
7
Association between abnormal serum free light chains ratio and known prognostic factors in lymphoma; a nephrology viewpoint.
J Renal Inj Prev. 2016 Dec 15;6(2):148-152. doi: 10.15171/jrip.2017.29. eCollection 2017.
8
Four synchronous cancers in a patient with tongue pain as the only symptom.
BMJ Case Rep. 2016 May 5;2016:bcr2015214047. doi: 10.1136/bcr-2015-214047.
10
Racial differences in three major NHL subtypes: descriptive epidemiology.
Cancer Epidemiol. 2015 Feb;39(1):8-13. doi: 10.1016/j.canep.2014.12.001. Epub 2015 Jan 2.

本文引用的文献

1
Minimal residual disease detection in lymphoma and multiple myeloma: impact on therapeutic paradigms.
Hematol Oncol. 2011 Dec;29(4):167-76. doi: 10.1002/hon.989. Epub 2011 Apr 2.
2
Risk Factors of Non-Hodgkin Lymphoma.
Expert Opin Med Diagn. 2011 Nov 1;5(6):539-550. doi: 10.1517/17530059.2011.618185.
3
Follicular lymphoma: 2011 update on diagnosis and management.
Am J Hematol. 2011 Sep;86(9):768-75. doi: 10.1002/ajh.22099.
4
Diagnosis and treatment of follicular lymphoma.
Swiss Med Wkly. 2011 Aug 4;141:w13247. doi: 10.4414/smw.2011.13247. eCollection 2011.
5
New agents in follicular lymphoma.
Best Pract Res Clin Haematol. 2011 Jun;24(2):305-12. doi: 10.1016/j.beha.2011.03.006. Epub 2011 May 11.
7
Identification of predictive pathways for non-hodgkin lymphoma prognosis.
Cancer Inform. 2010 Dec 7;9:281-92. doi: 10.4137/CIN.S6315.
8
SNP rs6457327 in the HLA region on chromosome 6p is predictive of the transformation of follicular lymphoma.
Blood. 2011 Mar 17;117(11):3147-50. doi: 10.1182/blood-2010-10-315382. Epub 2011 Jan 13.
9
Gene expression profiling in follicular lymphoma and its implication for clinical practice.
Leuk Lymphoma. 2011 Jan;52(1):59-68. doi: 10.3109/10428194.2010.531412. Epub 2010 Dec 6.
10
Prognostic tools in follicular lymphomas.
Expert Rev Hematol. 2009 Oct;2(5):549-62. doi: 10.1586/ehm.09.34.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验